This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maugeais, C. Articles by Krempf, M. Search for Related Content PubMed PubMed Citation Articles by Maugeais, C. Articles by Krempf, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cholesterol

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1369-1375.)
© 1997 American Heart Association, Inc.

Articles

Lipoprotein Kinetics in Patients With Analbuminemia

Evidence for the Role of Serum Albumin in Controlling Lipoprotein Metabolism

C. Maugeais; S. Braschi; K. Ouguerram; P. Maugeais; P. Mahot; B. Jacotot; D. Darmaun; T. Magot; ; M. Krempf

From the Centre de Recherche en Nutrition Humaine, Hôpital G. & R. Laënnec, Nantes, France (C.M., K.O., P.M., D.D., T.M., M.K.); Service de Médecine Interne, Hôpital Henri Mondor, Créteil, France (S.B., B.J.); and Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France (P.M., M.K.).

Correspondence to Michel Krempf, Clinique d'Endocrinologie, Hôtel Dieu, 44093 Nantes cedex 01, France. E-mail mkrempf{at}micronet.fr.

Abstract In vitro data suggested that albumin is a key factor controlling apolipoprotein (apo) synthesis by hepatocytes. Studies in analbuminemic rats have shown an increase in secretion of apoB-containing lipoprotein from the liver. We studied the kinetic aspects of apoB- and apoAI-containing lipoprotein metabolism in two sisters with analbuminemia using a constant 14-hour infusion of leucine labeled with stable isotopes. Compared with control subjects, total cholesterol was higher in the two patients (432 and 461 versus 155±14 mg/dL), as was apoB (257 and 230 versus 72±7 mg/dL). Triglycerides were slightly increased (134 and 105 versus 89±9 mg/dL), whereas apoAI was lower (109 and 105 versus 124±6 mg/dL). VLDL–apoB production was higher, as was the production of IDL–apoB and LDL–apoB (32.8 and 36.0 versus 24.8±5.9, 32.1 and 27.2 versus 16.4±2.3, and 14.1 and 17.6 versus 10.3±1.2 mg · kg^-1 · d^-1, respectively). The fractional catabolic rate of all the apoB-containing lipoproteins was decreased (0.23 and 0.37 versus 0.48±0.05, 0.27 and 0.28 versus 0.62±0.08, and 0.012 and 0.009 versus 0.022±0.002 · h^-1, respectively). A similar mechanism could explain the dyslipidemia observed in other conditions associated with low albumin levels, such as nephrotic syndrome.

Key Words: nephrotic syndrome • dyslipidemia • compartmental analysis • apoB • apoAI

This article has been cited by other articles:

				J. Monks and M. C Neville Albumin transcytosis across the epithelium of the lactating mouse mammary gland J. Physiol., October 1, 2004; 560(1): 267 - 280. [Abstract] [Full Text] [PDF]

				C. Maugeais, K. Ouguerram, R. Frénais, P. Maugère, B. Charbonnel, T. Magot, and M. Krempf Effect of Low-Density Lipoprotein Apheresis on Kinetics of Apolipoprotein B in Heterozygous Familial Hypercholesterolemia J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1679 - 1686. [Abstract] [Full Text]